Newsroom

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Compass Minerals International, Inc. (NYSE: CMP) (“Compass Minerals” or the “Company”) today announced that S&P Global Ratings has upgraded the Company’s corporate credit rating to ‘B+’ from ‘B’, with a stable outlook. S&P also upgraded the rating on the Company’s senior secured debt to ‘BB’ from ‘BB-‘ and senior unsecured debt to ‘B+’ from ‘B’. In addition, S&P’s ‘1’ recovery rating on the secured debt and ‘4’ recovery rating on the unsecured de...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 26.06.2026 FKUD IE00BD9N0445  121,463.00 GBP   3,654,834.53   30.090  ...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced its addition to the Russell 2000® Index, effective at the close of U.S. equity markets on June 26, 2026, according to the final list of additions published by FTSE Russell. The annual reconstitution of the Russell U.S. indexes ranks eligible U.S. sto...

CHICAGO--(BUSINESS WIRE)--The Federal Home Loan Bank of Chicago (FHLBank Chicago) today opened applications for its 2026 Community First® Developer Program (Developer Program), a grant initiative that helps organizations train and develop the next generation of affordable housing professionals across Illinois and Wisconsin. FHLBank Chicago will award up to $3 million, delivered through its financial institution members to eligible organizations. Grants will range from $50,000 to $200,000, and a...

TAMPA BAY, Fla.--(BUSINESS WIRE)--KnowBe4, the global leader in digital workforce security, securing both AI agents and humans, today announced the official launch of its 35th interactive game, Spot the Vish. This latest addition to the KnowBe4 game library is designed to train the digital workforce to recognize, resist, and report voice phishing (vishing) attacks in real time. Vishing attacks have grown increasingly sophisticated, often involving bad actors posing as IT support or C-level exec...

ANN ARBOR, Mich.--(BUSINESS WIRE)--Concorde Investment Services, a leading independent broker-dealer and registered investment advisor serving financial professionals nationwide, has hired Marc A. Morell as chief compliance officer."Marc brings exactly the kind of seasoned, hands-on compliance leadership Concorde needs as we continue to grow," said Danielle Delongchamp, president and chief executive officer of Concorde. "His depth of experience leading broker-dealer compliance, advisor governanc...

OTTAWA, Ontario--(BUSINESS WIRE)--Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain planning and orchestration, today announced that MANE, one of the top five leading organizations worldwide in the flavours and fragrances industry, has selected Kinaxis to modernize its planning capabilities as it accelerates global growth as part of a broader enterprise-wide transformation initiative. Headquartered in the south of France, with a significant global footprint spanning multiple region...

WOBURN, Mass.--(BUSINESS WIRE)--SES AI Corporation (“SES AI,” the “Company,” “we” or “us”) (NYSE: SES), a global leader in the development and manufacturing of AI-enhanced high-performance Li-Metal and Li-ion batteries, today announced that it has been added to the Russell 3000® Index. The newly reconstituted Russell 3000® Index will begin trading at the market open on Monday, June 29, 2026. Russell indexes are widely used by investment managers and institutional investors for index funds and a...

JACKSONVILLE, Fla.--(BUSINESS WIRE)--The Winn-Dixie Company donates $100,000 to the USO ahead of Independence Day...

NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced updated, positive data from its Phase 1/2 clinical trial evaluating NGN-401 gene therapy for the treatment of females with Rett syndrome. Across 10 participants, 47 total developmental milestones were gained (average of 4.7 per participant), with both pediatric and adolescent/adult par...